Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial

To investigate whether extracorporeal shock wave therapy (ESWT) is noninferior to botulinum toxin type A (BoNT-A) for the treatment of poststroke upper limb spasticity.
Source: Archives of Physical Medicine and Rehabilitation - Category: Rehabilitation Authors: Tags: Original research Source Type: research
More News: Botox | Rehabilitation